185 related articles for article (PubMed ID: 32028608)
21. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.
Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S
Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601
[TBL] [Abstract][Full Text] [Related]
22. Instructed Assembly of Peptides for Intracellular Enzyme Sequestration.
Feng Z; Wang H; Xu B
J Am Chem Soc; 2018 Dec; 140(48):16433-16437. PubMed ID: 30452246
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the anti-inflammatory properties of NCX 429, a dual-acting compound releasing nitric oxide and naproxen.
Amoruso A; Fresu LG; Dalli J; Miglietta D; Bardelli C; Federici Canova D; Perretti M; Brunelleschi S
Life Sci; 2015 Apr; 126():28-36. PubMed ID: 25711428
[TBL] [Abstract][Full Text] [Related]
24. Discovery of 5-Methylthiazole-Thiazolidinone Conjugates as Potential Anti-Inflammatory Agents: Molecular Target Identification and In Silico Studies.
Haroun M; Petrou A; Tratrat C; Kolokotroni A; Fesatidou M; Zagaliotis P; Gavalas A; Venugopala KN; Sreeharsha N; Nair AB; Elsewedy HS; Geronikaki A
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500230
[TBL] [Abstract][Full Text] [Related]
25. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
26. Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer.
Aliabadi A; Khanniri E; Mahboubi-Rabbani M; Bayanati M
Eur J Med Chem; 2023 Dec; 261():115866. PubMed ID: 37862815
[TBL] [Abstract][Full Text] [Related]
27. Novel aryl carboximidamide and 3-aryl-1,2,4-oxadiazole analogues of naproxen as dual selective COX-2/15-LOX inhibitors: Design, synthesis and docking studies.
Youssif BGM; Mohamed MFA; Al-Sanea MM; Moustafa AH; Abdelhamid AA; Gomaa HAM
Bioorg Chem; 2019 Apr; 85():577-584. PubMed ID: 30878890
[TBL] [Abstract][Full Text] [Related]
28. Computational Design, Synthesis, and Pharmacological Evaluation of Naproxen-Guaiacol Chimera for Gastro-Sparing Anti-Inflammatory Response by Selective COX2 Inhibition.
Shinu P; Sharma M; Gupta GL; Mujwar S; Kandeel M; Kumar M; Nair AB; Goyal M; Singh P; Attimarad M; Venugopala KN; Nagaraja S; Telsang M; Aldhubiab BE; Morsy MA
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296501
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of anti-inflammatory and immunomodulatory effects of Premna integrifolia extracts and assay-guided isolation of a COX-2/5-LOX dual inhibitor.
Azad R; Babu NK; Gupta AD; Reddanna P
Fitoterapia; 2018 Nov; 131():189-199. PubMed ID: 30339925
[TBL] [Abstract][Full Text] [Related]
30. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [
Mohammadi R; Shokri B; Shamshirian D; Zarghi A; Shahhosseini S
Daru; 2020 Jun; 28(1):87-96. PubMed ID: 31845157
[TBL] [Abstract][Full Text] [Related]
32. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
33. Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study.
Hegazy ME; Taher ES; Ghiaty AH; Bayoumi AH
Bioorg Chem; 2024 Apr; 145():107244. PubMed ID: 38428284
[TBL] [Abstract][Full Text] [Related]
34. New Substituted 5-Benzylideno-2-Adamantylthiazol[3,2-b][1,2,4]Triazol-6(5
Tratrat C; Haroun M; Paparisva A; Kamoutsis C; Petrou A; Gavalas A; Eleftheriou P; Geronikaki A; Venugopala KN; Kochkar H; Nair AB
Molecules; 2021 Jan; 26(3):. PubMed ID: 33513963
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
[TBL] [Abstract][Full Text] [Related]
36. Exploring the potential of propanamide-sulfonamide based drug conjugates as dual inhibitors of urease and cyclooxygenase-2: biological and their
Ahmad S; Abdul Qadir M; Ahmed M; Imran M; Yousaf N; Wani TA; Zargar S; Ali I; Muddassar M
Front Chem; 2023; 11():1206380. PubMed ID: 37601915
[TBL] [Abstract][Full Text] [Related]
37. Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β.
Cheleschi S; Pascarelli NA; Valacchi G; Di Capua A; Biava M; Belmonte G; Giordani A; Sticozzi C; Anzini M; Fioravanti A
Int Immunopharmacol; 2015 Sep; 28(1):794-801. PubMed ID: 26292179
[TBL] [Abstract][Full Text] [Related]
38. Supramolecular nanofiber of indomethacin derivative confers highly cyclooxygenase-2 (COX-2) selectivity and boosts anti-inflammatory efficacy.
Lin D; Xu X; Chen L; Chen L; Deng M; Chen J; Ren Z; Lei L; Wang J; Deng J; Li X
J Control Release; 2023 Dec; 364():272-282. PubMed ID: 37866406
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
Omar YM; Abdu-Allah HHM; Abdel-Moty SG
Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191
[TBL] [Abstract][Full Text] [Related]
40. N-(9-Fluorenylmethoxycarbonyl)-L-Phenylalanine/nano-hydroxyapatite hybrid supramolecular hydrogels as drug delivery vehicles with antibacterial property and cytocompatibility.
Li W; Hu X; Chen J; Wei Z; Song C; Huang R
J Mater Sci Mater Med; 2020 Jul; 31(8):73. PubMed ID: 32729101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
